DIAGNOS Announces Grant of Stock Options

BROSSARD, QUEBEC, CANADA--(Marketwire - Aug. 28, 2012) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (ADK.V), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that the Board of Directors has approved a grant of 900,000 stock options to its directors and officers under the terms of the stock option plan of the Corporation approved by the Shareholders in September 2008.

The exercise price of these options has been established at C$0.16 per share. Grants of stock options vest at the rate of 33.33% per year, commencing with the first anniversary of the grant. The expiry date to which these options can be exercised has been fixed to August 26, 2017.

About DIAGNOS

Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.